05/11/2019

QUB Partakes In New Cystic Fibrosis Trial

Researchers at Queen's University Belfast have been involved in ground-breaking research that holds promise for a vast majority of those with cystic fibrosis.

The researchers identified how a combination of three drugs known as 'triple therapy' can successfully treat the majority of people living with CF by tackling the underlying cause of the disease.

The research comes in the wake of confirmation that life-saving drugs Orkambi and Symkevi are to be made available to local patients.

The new trial involves a drug that targets the root cause of cystic fibrosis, a genetic condition which clogs up the lungs and digestive system, making breathing difficult resulting in an early death for those affected.

Cystic fibrosis is a genetic condition affecting more than 10,400 people in the UK. It is a progressive and life-threatening disease which results in the formation of thick mucus that builds up in the lungs and other parts of the body. It leads to severe respiratory infections that damage the lungs and cause them to fail.
News Image
CF is caused by a defective protein that results from mutations in the CFTR gene. The most common mutation is the F508del mutation. Although there is currently no cure for CF, it is possible to help control the symptoms and delay complications to make the condition easier to live with.

Dr Damian Downey is a Clinical Senior Lecturer at the Wellcome-Wolfson Institute for Experimental Medicine co-author on the worldwide trial to assess the safety and efficacy of a new triple drug combination (TRIKAFTATM) in patients with CF aged 12 years and older. The study involved a four-week, randomized, double-blind, active-controlled trial in 107 patients who had two copies of the F508del mutation.

Dr Downey explained: "The trial was a success in demonstrating that this drug combination can potentially treat up to 90% of people with CF by addressing the underlying cause of their disease. This new 'triple therapy' has the potential to transform the lives of people with CF. It results in a significant improvement in lung function and quality of life and also reduces the frequency of chest infections. This treatment will likely alter the future of CF care."

The study was conducted with funding from Vertex Pharmaceuticals, which developed the triple-combination drug therapy, known as Trikafta. Last week, the Food and Drug Administration approved Trikafta for use with about 90 percent of patients with cystic fibrosis — those who have the most common cystic fibrosis gene mutation and are 12 or older.



(JG/CM)

Related Northern Ireland News Stories
Click here for the latest headlines.

09 December 2021
Range Of New Treatment Options For Covid-19 Patients Announced
The UK government has announced a range of new treatment options for COVID-19 patients who are at the highest risk from the effects of the virus. To date, most COVID-19 treatments have focused on hospitalised patients.
19 November 2020
13.2% Of NI Young People Not In Education, Employment Or Training
An estimated 26,000 young people aged 16-24 in Northern Ireland were not in education, employment or training (NEET) between July and September 2020, according to the latest statistics. The figures is the equivalent to 13.2% of all those aged 16-24 years, and shows that the NI number is higher that the UK average of 12.4%.
10 November 2020
Around 285,000 People Could Be Vaccinated Pending Licensing
Around 285,000 people could be vaccinated against Covid-19, if the potential new vaccine passes the next stage of trails. It is understood that NI could receive some 570,000 doses of the vaccine if it becomes licensed.
16 December 2021
Man Dies In Three Car Collision In Dundrum
Police have issued an appeal for information following a fatal collision in Dundrum, Co Down. A 49-year-old man died at the scene of a three-car collision on the Belfast Road at about 12:20am on Thursday. It is understood that four other people are being treated in hospital following the collision.
15 December 2021
Minister Urges People To 'Have Their Say' On Green Growth Strategy
Minister for Agriculture, Environment and Rural Affairs Edwin Poots has urged people to respond to a consultation on the proposed Green Growth Strategy.